曼恩凱德生物醫療MNKD
那斯達克 · USD
2.73
-0.10
(-3.37%)
盤中 03/12 10:19 (UTC+8)
03/12 10:19 (UTC+8)
曼恩凱德生物醫療MNKD
2.73
-0.10
(-3.37%)
財務數據
損益表
- 0.51
- 0.58
- 0.66
- 0.72
- 0.70
- 0.77
- 0.78
- 0.77
- 0.82
- 1.12
- 5.43
- 14.09
- 13.32
- 9.24
- -3.19
- 9.56
- 2.06
- -2.33
- 7.32
- 36.31
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 111,955 | 82,130 | 76,527 | 78,354 | 76,776 | 70,079 | 72,386 | 66,263 | 58,472 | 51,253 |
營業成本 | 29,673 | 20,203 | 20,568 | 17,516 | 19,604 | 18,023 | 20,377 | 18,598 | 18,067 | 14,254 |
營業毛利 | 82,282 | 61,927 | 55,959 | 60,838 | 57,172 | 52,056 | 52,009 | 47,665 | 40,405 | 36,999 |
營業費用 | 89,972 | 43,151 | 45,297 | 36,036 | 35,110 | 36,842 | 35,928 | 32,342 | 29,771 | 33,967 |
研發費用 | 27,588 | 14,063 | 13,675 | 11,022 | 11,138 | 12,926 | 11,816 | 10,013 | 9,236 | 9,989 |
推銷及管理費用 | 58,411 | 29,088 | 31,622 | 25,014 | 23,972 | 23,916 | 24,112 | 22,329 | 20,535 | 23,978 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 3,973 | - | - | - | - | - | - | - | - | - |
營業利益 | -7,690 | 18,896 | 5,299 | 22,293 | 26,495 | 12,760 | 16,610 | 16,722 | 7,858 | 5,097 |
其他收入及費用 | 631 | -3,661 | -3,531 | -553 | -6,136 | 6,016 | -4,894 | 4,833 | -2,317 | 3,963 |
利息費用 | 13,872 | 7,334 | 6,191 | 10,632 | 7,481 | 8,360 | 12,878 | 9,262 | 5,355 | 5,274 |
稅前純益 | -20,931 | 7,781 | 940 | 13,617 | 8,445 | 12,870 | -1,691 | 10,894 | 2,962 | 1,721 |
所得稅 | -4,983 | -204 | 272 | 459 | 1,023 | 1,320 | 323 | 264 | 1,561 | - |
稅後純益 | -15,948 | 7,985 | 668 | 13,158 | 7,422 | 11,550 | -2,014 | 10,630 | 1,401 | 1,721 |
基本每股稅後盈餘(元) | -0.05 | 0.03 | 0.00 | 0.04 | 0.03 | 0.04 | -0.01 | 0.04 | - | 0.01 |
稀釋每股稅後盈餘(元) | -0.05 | 0.03 | 0.00 | 0.04 | 0.03 | 0.04 | -0.01 | 0.04 | 0.01 | 0.01 |
基本平均股數(千股) | 307260.00 | 306806.00 | 304954.00 | 303481.00 | 279191.00 | 274998.00 | 273056.00 | 270356.00 | - | 268732.00 |
稀釋平均股數(千股) | 307260.00 | 311638.00 | 311484.00 | 320897.00 | 290631.00 | 284693.00 | 273056.00 | 324733.00 | - | 323770.00 |
還原基本每股稅後盈餘(元) | -0.05 | 0.03 | 0.00 | 0.04 | 0.03 | 0.04 | -0.01 | 0.04 | - | 0.01 |
還原稀釋每股稅後盈餘(元) | -0.05 | 0.03 | 0.00 | 0.04 | 0.03 | 0.04 | -0.01 | 0.04 | 0.01 | 0.01 |
還原基本平均股數(千股) | 307,260 | 306,806 | 304,954 | 303,481 | 279,191 | 274,998 | 273,056 | 270,356 | - | 268,732 |
還原稀釋平均股數(千股) | 307,260 | 311,638 | 311,484 | 320,897 | 290,631 | 284,693 | 273,056 | 324,733 | - | 323,770 |
EBITDA(千元) | -2,768 | 17,507 | 9,099 | 26,089 | 17,600 | 22,603 | 12,527 | 21,362 | 9,875 | 9,056 |